Delivery Order SPE2DB20D3101-SPE2DB23FRYD6
Award Date
9/19/23
Potential Completion Date
9/20/23
Potential Value
$54K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Prilosec DR 2.5 mg suspension 30s to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,105.68, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award, valued at $6,930.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the provision of Prilosec DR 2.5 MG Suspension 30S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3101|SPE2DB24FRBE2) from the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg Suspension, valued at $12,325.17. The contract has a ceiling value of $12,325.17 and an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,475.62 Delivery Order (SPE2DB23FRVD2) is for the supply of 30 suspension packages of the drug Prilosec 10 mg. The contract has a firm fixed price and an ultimate completion date of August 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,914.80, is for the supply of Prilosec DR 10 mg suspension medication in 30-count packages. The contract has an ultimate completion date of November 19, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of PRILOSEC DR 2.5 MG SUSPENSION 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $3,510.88 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This federal contract award, with an ID of SPE2DX15D2106 and SPE2DX23F1K3G, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,980.24 firm fixed-price delivery order is for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S, a pharmaceutical product. This award is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, SPE2DX15D2105|SPE2DX23F7JC2, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,472.40 firm fixed price delivery order is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a pharmaceutical product. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,366.53 from the Defense Logistics Agency Troop Support Medical to supply 30 units of Prilosec DR 10 mg suspension by November 17, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was awarded under an existing indefinite-delivery contract held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,282.56 firm fixed-price delivery order is for the supply of First-Omeprazole 2 mg/ml suspension with a completion date of December 27, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...